Stock data
Novartis$105.85
NOVN 
0.65% • 24 H
0.65% • 24 HDividend Yield:3.3%
Global Rank#48
Market Cap$217.57B
YTD Performance9.70%
P/E0
Revenue$46.66B
Change 7d4.57%
SP500 BenchmarkUnderperform
Country🇨🇭 Switzerland
P/S4.66
Earnings$14.85B
Dividend Yield:3.3%
Main Sector
Healthcare
Novartis (NOVN) Cash on Hand
NOVN Cash on Hand in 2022: $13.96B
According to Novartis latest financial reports the cash on hand of NOVN is $13.96B, an decrease of -25.00% to 2022. At the end of 2022 company had $18.61B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
NOVN Cash on Hand History from 2018 to 2023
-
Value:-
NOVN Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $13.96B | -25.00% |
| 2022 | $18.61B | -33.79% |
| 2021 | $28.11B | 148.94% |
| 2020 | $11.29B | -1.34% |
| 2019 | $11.45B | -28.30% |
| 2018 | $15.96B | - |
View the Top Cash on Hand Companies 
